3 Drugs That Could Make-or-Break AbbVie Post author:Sam Post published:February 11, 2018 Post category:BioPharma A look at three drug approvals of vital importance to the company this year. Source: BioSpace You Might Also Like Akebia Announces Pricing Of Public Offering Of Common Stock June 28, 2017 Novartis AG Hires Bank of America to Officially Review Alcon Options April 20, 2017 Johns Hopkins Gets a $65M Boost to Take Promising Drugs Into Clinic November 15, 2017
